Translation: Original published in Finnish on 06/12/2026 at 08:11 am EEST

Nexstim announced on Thursday that it had received an order for ten NBS 6 systems from its distributor. The systems will be delivered to the US and Europe during the first and second halves of the current year. The release instills confidence in our growth estimates for this year.

A large one-off order from a distributor refers to Brainlab

According to the release, the ordered systems include both diagnostic and therapy features. Although Nexstim did not name the distributor in the press release, we consider it likely to be the company's strategic partner, Brainlab. Last year, Nexstim announced numerous individual system deliveries between May and August. This year, it appears that a similar order intake has materialized as the single largest order in Nexstim's history. We also expect future deals through distributors to materialize as larger one-time orders compared to before. Prior to this, Nexstim had already reported three systems sold through distributors this year, so this sales channel appears to be on a clear growth trajectory. This is in line with our expectations, as Nexstim has stated that the Brainlab collaboration will begin to yield results more fully from 2026–27 onwards. 

Important support for this year's growth estimates

Nexstim's early year was seasonally quiet in terms of system deliveries, as the company delivered three systems in Q1. We have been expecting system sales to pick up clearly towards the end of the year, supported by Brainlab's sales resources. The now announced order for ten systems is large by Nexstim's standards (2025:   37 deliveries), and it is in line with the development we estimate. We expect the company's full-year 2026 revenue to grow by just under 16% to 12.7 MEUR, which will largely rely on double-digit growth in equipment sales. As the order's deliveries are scheduled for both H1 and H2, we believe it supports our full-year estimates.